Your browser doesn't support javascript.
loading
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir.
Torii, Shiho; Kim, Kwang Su; Koseki, Jun; Suzuki, Rigel; Iwanami, Shoya; Fujita, Yasuhisa; Jeong, Yong Dam; Ito, Jumpei; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Sato, Kei; Matsuura, Yoshiharu; Shimamura, Teppei; Iwami, Shingo; Fukuhara, Takasuke.
Afiliação
  • Torii S; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Kim KS; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Koseki J; Division of Systems Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Suzuki R; Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Iwanami S; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Fujita Y; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Jeong YD; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Ito J; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Asakura H; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Nagashima M; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Sadamasu K; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Yoshimura K; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Sato K; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Matsuura Y; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Shimamura T; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Iwami S; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Fukuhara T; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
PLoS Pathog ; 19(3): e1011231, 2023 03.
Article em En | MEDLINE | ID: mdl-36972312
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão